PT  - JOURNAL ARTICLE
AU  - Helwick, Caroline
ED  - Nordlinger, NBernard
TI  - Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver Metastases
DP  - 2007 Sep 01
TA  - MD Conference Express
PG  - 14--15
VI  - 7
IP  - 3
4099  - http://mdc.sagepub.com/content/7/3/14.short
4100  - http://mdc.sagepub.com/content/7/3/14.full
AB  - Perioperative chemotherapy provided benefit for patients with colorectal cancer who were treated with surgery for potentially resectable liver metastases. This article discusses the final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 evaluating the benefit of perioperative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases.